Fox Chase Cancer Center Introduces Hospitalist Program
PHILADELPHIA (March 17, 2006) - Internist T. Rogers Kyle, MD, joined the department of medical oncology at Fox Chase Cancer Center as director of the new hospitalist service. Dr. Kyle is responsible for coordinating inpatient care, communicating with referring physicians, discharge planning and supervision of house staff. He works in concert with attending physicians and fellows as well as with residents and students assigned to cover the inpatient service.
Hospitalist services, also called hospital medicine, are a relatively new phenomenon. It has evolved only over the last 10 years.
At Fox Chase, the hospitalist service enhances the continuum of care by providing an additional level of support for patients who may be dealing with diseases in addition to cancer or suffering from complications of cancer or cancer treatments.
"The development of the hospitalist service allows Fox Chase to provide our inpatients with the depth and breadth of excellence in all aspects of their medical care," said Louis M. Weiner, M.D., chairman of medical oncology and vice president for translational research. "It allows our medical oncologists to truly focus on our patients' cancer-related needs with confidence that their other complex medical needs are being addressed by expert internists."
Fox Chase has a full complement of specialists available, including active and consulting staff, to address non-cancer-related medical problems for inpatients. Fox Chase gastroenterologists and pulmonologists provide round-the-clock coverage. Other specialists include cardiology, endocrinology, infectious diseases, nephrology, psychiatry, rehabilitation, rheumatology, podiatry and dentistry.
The new program makes Fox Chase one of only a few cancer centers in the nation with a hospitalist program, including Memorial Sloan-Kettering Cancer Center in New York City and University of Texas M. D. Anderson Cancer Center in Houston.
Before coming to Fox Chase, Kyle was a member of the medical staff at Chestnut Hill Hospital. He has held a number of clinical and administrative responsibilities at both Chestnut Hill Hospital and the Hospital of the University of Pennsylvania, including chief of the internal medicine section at Chestnut Hill, senior vice president and medical director for the integrated services division of Chestnut Hill HealthCare, medical director of managed care for the University of Pennsylvania Health System and senior medical director for the system's office of network development.
Kyle received his bachelor's degree at Princeton University and his M.D. at the University of Pennsylvania Medical School in 1979. He completed his internship and residency in internal medical at the Medical College of Virginia and served on the faculty there before returning to Philadelphia to join the University of Pennsylvania medical faculty in 1983.
Fox Chase Cancer Center, part of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. For more information, call 1-888-FOX CHASE or (1-888-369-2427).
Media inquiries only, please contact Jeremy Moore at 215-728-2700.